24-wk Efficacy and Safety of Flibanserin vs Pbo in Naturally Postmenopausal Women in United States.

Trial Profile

24-wk Efficacy and Safety of Flibanserin vs Pbo in Naturally Postmenopausal Women in United States.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Jul 2014

At a glance

  • Drugs Flibanserin (Primary)
  • Indications Decreased libido
  • Focus Therapeutic Use
  • Acronyms SNOWDROP
  • Sponsors Sprout Pharmaceuticals
  • Most Recent Events

    • 02 Mar 2012 Company added in the association field as reported by ClinicalTrials.gov.
    • 11 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top